NCT02992236View on ClinicalTrials.gov

Effects of the NO-synthase Inhibitor VAS203 on Renal Function in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

November 30, 2016

Conditions
Renal Function Impairment in Healthy Volunteers
Interventions
DRUG

VAS203

Infusion of NO-Synthase inhibitor VAS203

DRUG

Saline

Infusion of saline

Trial Locations (1)

91054

Universitätsklinik Erlangen, Erlangen

All Listed Sponsors
collaborator

Winicker Norimed GmbH

INDUSTRY

lead

veriNOS operations GmbH

INDUSTRY

NCT02992236 - Effects of the NO-synthase Inhibitor VAS203 on Renal Function in Healthy Volunteers | Biotech Hunter | Biotech Hunter